Crossmark

6-Hydroxy-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline Demonstrates Neuroprotective Properties in Experimental Parkinson's Disease by Enhancing the Antioxidant System, Normalising Chaperone Activity and Suppressing Apoptosis

Crossref DOI link: https://doi.org/10.1007/s11064-024-04125-9

Published Online: 2024-03-19

Published Print: 2024-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kryl’skii, Evgenii D.

Razuvaev, Grigorii A.

Popova, Tatyana N.

Oleinik, Sergei A.

Medvedeva, Svetlana M.

Shikhaliev, Khidmet S.
Funding

Funding for this research was provided by:

Council for Grants of President of Russian Federation for Young Scientists-Candidates of Sciences (МК-4905.2022.1.40000)
License Information

Text and Data Mining valid from 2024-03-19

Version of Record valid from 2024-03-19
More Information

Article History

Received: 14 November 2023

Revised: 6 February 2024

Accepted: 10 February 2024

First Online: 19 March 2024

Declarations

:

: The authors have no relevant financial or non-financial interests to disclose.

: Ethics Committee on Biomedical Research Expertise in Voronezh State University. Approval Code: № 42-02. Approval Date: 4 October 2021.

Document is current

Any future updates will be listed below